Co-Founder, Chief Scientific Officer
Alicia has 20 years of industry R&D experience in the microbiology, biotechnology and microarray fields. As a research scientist at Agilent Technologies, she developed the technology behind the $60+ million microarray CGH product line. She has created novel products in the area of DNA probe design, nucleic acid labeling and hybridization methods and devices, data analysis, microscopy and imaging, and bacterial identification. She is passionate about the microbiome, genomic technology, and using data as tool to answer important questions. Alicia holds a BA in Microbiology from Miami University, and left a PhD program in Immunology at Duke University to pursue more compelling opportunities. In her spare time, she enjoys yoga, swimming, making, and playing with her family.
Co-Founder, Chief Executive Officer
After a several opportunities with startups, government, and other corporations, Jeff Rosner joined Hewlett-Packard (HP) in 1978. There he has held a variety of management and individual contributor positions in operating divisions and the corporate laboratories. When Agilent was formed from the instrumentation core of HP’s business, Jeff joined the new company, where he has been deeply involved in technology acquisition. His increasing interest in biotechnology led him to leave Agilent for Life Technologies (the merger of Invitrogen and Applied Biosystems), where he served as Chief Technology Officer for the Genetic Analysis franchise. He is currently an independent consultant working on several biotechnology projects.
Jeff has authored or co-authored over 50 journal articles and 15 awarded U.S. patents. He holds a BS in Electrical Engineering from the Massachusetts Institute of Technology and an MS and Ph.D. from Stanford University in Materials Science.